Intensifying Insulin Therapy from Basal Insulin to Biphasic Insulin Aspart (BIAsp 30) Improves Glucose Control and Treatment Satisfaction in Patients with Type 2 Diabetes: South Korea Subgroup of IMPROVE™ Study

被引：0

|

作者：

Kim, Chong Hwa

Jeong, Su Jin

Mok, Ji Oh

Ryu, Ohk Hyun

Lee, Kiyoung

Jeong, In Kyung

Lee, Byung Wan

Kim, Hyun Jin

Lee, Sora

Kim, Sun Woo

机构：

来源：

DIABETES | 2010年 / 59卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A566 / A566

页数：1

相关论文

共 50 条

[41] Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: Results from a large, observational study
Jang, Hak Chul
Lee, So Ra
Bech, Ole M.
DIABETES, 2008, 57 : A135 - A135
[42] Biphasic insulin aspart 30 treatment improves glycemic control among patients with type 2 diabetes in Saudi Arabia and the Gulf region
Ayad, Nasrat M.
Fattah, Waleed A.
Bakry, Hani
SAUDI MEDICAL JOURNAL, 2008, 29 (06) : 919 - 920
[43] Differences in Insulin Treatment Satisfaction Following Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes
Farmer, Andrew J.
Oke, Jason
Stevens, Richard
Holman, Rury R.
DIABETES, 2009, 58 : A130 - A130
[44] Economic Impact of Intensifying Basal Insulin with Insulin Aspart among Patients with Type 2 Diabetes: A US Real-World Study
Sun, Peter
Lian, Jean
Karolicki, Boris
DIABETES, 2014, 63 : A299 - A300
[45] Insulin degludec/insulin aspart vs biphasic insulin aspart 30 twice daily in Japanese patients with type 2 diabetes: A randomized controlled trial
Onishi, Yukiko
Yamada, Kenichi
Zacho, Jeppe
Ekelund, Jan
Iwamoto, Yasuhiko
JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (02) : 210 - 217
[46] Biphasic Insulin Aspart 30/70 (BIAsp 30) Is Well Tolerated Effective in Patients ≥75 Years Old in the IMPROVE™ Study
Borzi, Vito
Rosenberg, Kristine Horn
Benroubi, Marian
DIABETES, 2010, 59 : A554 - A555
[47] Patients with Type 2 diabetes mellitus have lower rates of nocturnal hypoglycaemia on biphasic insulin aspart (BIAsp30) than on biphasic human insulin-30 (BHI30): data from the REACH study
McNally, PG
Nelson, G
Fitch, M
DIABETOLOGIA, 2004, 47 : A327 - A327
[48] Patient treatment satisfaction before starting biphasic insulin aspart (BIAsp 30):: EMPROVE™ study data from China, Japan and Poland
Gumprecht, Janusz
Wenying, Yang
Valensi, Paul
Christensen, Torsten
Borzi, Vito
DIABETES, 2007, 56 : A506 - A506
[49] Starting or switching to biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes: A multicenter, observational, primary care study conducted in Finland
Makela, Jyrki K.
Schmuser, Christine
Askonen, Kari
Saukkonen, Tero
DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 95 (01) : 10 - 18
[50] Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin
Kilo, C
Mezitis, N
Jain, R
Mersey, J
McGill, J
Raskin, P
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2003, 17 (06) : 307 - 313

← 1 2 3 4 5 →